These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 16932674)

  • 1. Systemic lupus erythematosus--2005 annus mirabilis?
    Isenberg D; Rahman A
    Nat Clin Pract Rheumatol; 2006 Mar; 2(3):145-52. PubMed ID: 16932674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treating lupus: from serendipity to sense, the rise of the new biologicals and other emerging therapies.
    Sousa E; Isenberg D
    Best Pract Res Clin Rheumatol; 2009 Aug; 23(4):563-74. PubMed ID: 19591785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Newer therapeutic approaches for systemic lupus erythematosus: immunosuppressive agents.
    Dooley MA; Ginzler EM
    Rheum Dis Clin North Am; 2006 Feb; 32(1):91-102, ix. PubMed ID: 16504823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New treatments for SLE: cell-depleting and anti-cytokine therapies.
    Anolik JH; Aringer M
    Best Pract Res Clin Rheumatol; 2005 Oct; 19(5):859-78. PubMed ID: 16150407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Immunomodulation therapy for autoimmune diseases. New hope for patients with autoimmune diseases].
    Szegedi G
    Orv Hetil; 2005 Apr; 146(14):635-43. PubMed ID: 15889537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emerging biological drugs: a new therapeutic approach for Systemic Lupus Erythematosus. An update upon efficacy and adverse events.
    Murdaca G; Colombo BM; Puppo F
    Autoimmun Rev; 2011 Nov; 11(1):56-60. PubMed ID: 21835271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Update on emerging drug therapies for systemic lupus erythematosus.
    Mok CC
    Expert Opin Emerg Drugs; 2010 Mar; 15(1):53-70. PubMed ID: 20148712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Soluble mediators as therapeutic targets in systemic lupus erythematosus: cytokines, immunoglobulin receptors, and the complement system.
    Kirou KA; Salmon JE; Crow MK
    Rheum Dis Clin North Am; 2006 Feb; 32(1):103-19, ix. PubMed ID: 16504824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. B cells in SLE: different biological drugs for different pathogenic mechanisms.
    Diamanti AP; Rosado MM; Carsetti R; Valesini G
    Autoimmun Rev; 2007 Dec; 7(2):143-8. PubMed ID: 18035325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trials and tribulations in systemic lupus erythematosus.
    Wofsky D
    Bull NYU Hosp Jt Dis; 2010; 68(3):175-8. PubMed ID: 20969548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Update on immunotherapy for systemic lupus erythematosus--what's hot and what's not!
    Karim MY; Pisoni CN; Khamashta MA
    Rheumatology (Oxford); 2009 Apr; 48(4):332-41. PubMed ID: 19155279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biologics in SLE: the current status.
    Rajadhyaksha AG; Mehra S; Nadkar MY
    J Assoc Physicians India; 2013 Apr; 61(4):262-7. PubMed ID: 24482965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic lupus erythematosus in children: current and emerging therapies.
    Macdermott EJ; Adams A; Lehman TJ
    Lupus; 2007; 16(8):677-83. PubMed ID: 17711907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anticytokine therapy in systemic lupus erythematosus.
    Yoo DH
    Lupus; 2010 Oct; 19(12):1460-7. PubMed ID: 20947558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Newer therapeutic approaches for systemic lupus erythematosus.
    Ginzler EM; Dvorkina O
    Rheum Dis Clin North Am; 2005 May; 31(2):315-28. PubMed ID: 15922148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. B-cell-directed therapies in systemic lupus erythematosus.
    Tieng AT; Peeva E
    Semin Arthritis Rheum; 2008 Dec; 38(3):218-27. PubMed ID: 18206214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of systemic lupus erythematosus: new advances in targeted therapy.
    Lo MS; Tsokos GC
    Ann N Y Acad Sci; 2012 Jan; 1247():138-52. PubMed ID: 22236448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The B cell in systemic lupus erythaematosus: a rational target for more effective therapy.
    Driver CB; Ishimori M; Weisman MH
    Ann Rheum Dis; 2008 Oct; 67(10):1374-81. PubMed ID: 17720723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Longterm clinical and immunological effects of anti-CD20 treatment in patients with refractory systemic lupus erythematosus.
    Lindholm C; Börjesson-Asp K; Zendjanchi K; Sundqvist AC; Tarkowski A; Bokarewa M
    J Rheumatol; 2008 May; 35(5):826-33. PubMed ID: 18398943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic lupus erythematosus: modern strategies for management: a moving target.
    King JK; Hahn BH
    Best Pract Res Clin Rheumatol; 2007 Dec; 21(6):971-87. PubMed ID: 18068856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.